Delivery Order SPE2DB24D2101-SPE2DB25FKMNC
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $426,923.79 by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price contract, which was competitively awarded with no set-aside designation, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $20,049.12 by the Defense Logistics Agency's Medical Supply Chain on April 10, 2025, with completion scheduled for April 11, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $31,793.84 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,266.36 by the Defense Logistics Agency (DLA) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract, which is not set-aside and competitively awarded, calls for the delivery of Ibsrela 50 mg tablets in quantities of 60 units. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,024.38 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, designated as a non-set-aside award, is scheduled for completion by July 21, 2025, and represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2.27M by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, with a completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's extensive pharmaceutical and medical supply provision to federal defense healthcare systems. The award is a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $1,015.00 by the Defense Logistics Agency Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,704.06 by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025. This firm fixed-price, non-set-aside contract is classified as a child order under a larger indefinite delivery contract vehicle and is scheduled for completion by July 21, 2025. The award represents a routine pharmaceutical supply delivery supporting federal...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency Medical Supply Chain on July 18, 2025, with a ceiling value of $3,498.66 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger $999.9 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026. The award carries no...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $65,635.92 by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded order for pharmaceutical products and medical supplies to support federal military and healthcare operations. The award is structured as a...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMNCDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $18,339.50 on July 18, 2025, with an ultimate completion date of July 21, 2025. The award is for Gemtesa 75 mg tablets in a quantity of 90 units under a firm fixed price contract type with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. The Defense Logistics Agency's Medical Supply Chain relies on AmerisourceBergen's extensive federal contract portfolio to fulfill pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability to meet federal procurement standards through competitive award processes, combined with its established presence as a critical vendor in military and veteran healthcare procurement, positions the company as a key supplier within the DLA's pharmaceutical distribution network. The company continues to support the agency's medical logistics operations through both this specific delivery order and its overarching prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.3k | 7/18/25 |